NIGMS-Related Recovery Act News

NIGMS has invested $42.3 million of Recovery Act funds to launch 14 “Grand Opportunity” research projects that address critical gaps in the basic biomedical sciences.

NIGMS has invested $16.4 million of Recovery Act funds to jump-start a range of two-year research projects that address critical gaps in the basic biomedical and behavioral sciences.

A Nebraska researcher was recently selected to receive federal stimulus funds to extend his work on induced pluripotent stem cells.

An NIGMS Grand Opportunities stimulus grant will support research on how several plants make medicinal compounds.

NIGMS has issued a supplement grant to a researcher who is studying how the malaria parasite evolved resistance to the medication chloroquine.

Part of NIGMS's stimulus funds to study induced pluripotent stem cells will go to researchers in Wisconsin.

Texas Tech has received $800,000 in American Recovery and Reinvestment Act funds to assess how effective the laboratory method is at teaching physics and how well students understand the material.

NIGMS has issued a $600,000 grant to accelerate research into induced pluripotent stem cells (iPS), which can be reprogrammed into virtually any cell type.

NIH is using $67.4 million to support to support highly innovative research projects promising big payoffs.

NIGMS is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. 

NIGMS awarded a $2.5-million stimulus grant to the American Society for Cell Biology to establish an online open-access database called "The Cell: An Image Library."

NIGMS is funding a relatively large number of bioinformatics-related projects with stimulus grants.

NIH stiumulus grants to Emory include an NIGMS-funded study of the genome of voles, which are a good model for studying social attachment.

An NIGMS Grand Opportunities stimulus grant will support a study on whether genetic information in existing electronic medical records can be used to make drug administration safer.

New Mexico State University has received funding from the American Recovery and Reinvestment Act for its Bridges to the Baccalaureate program.

NIGMS grantee Robert Cohen has received funding from the American Recovery and Reinvestment Act to study the function of ubiquitin, a protein in cells that can lead to major disease depending on the path it takes.

NIGMS grantees Peter Lipke and Louise Hainline are among the researchers at Brooklyn College receiving funding from the American Recovery and Reinvestment Act.

NIGMS has awarded a "Grand Opportunities" grant to create an on-line image gallery of the cell that will be accessible to researchers, schools, and the public.

Three NIGMS-funded scientists, Susan Forsburg, Emily Scott and George O’Doherty, are among those receiving support from the American Recovery and Reinvestment Act.

NIGMS grantee Katsura Asano has received funding from the American Recovery and Reinvestment Act to study how eukaryotic cells initiate the process of building proteins.

Grambling State has received $4.5 million to continue funding the university’s MARC program.

The University of California, San Francisco, has received nearly $300,000 in federal economic stimulus funds to support the university’s Institutional Research and Academic Career Development Award program. 

The American Recovery and Reinvestment Act has provided funding for new research to learn more about how white blood cells work.

NIGMS grantee Stephen Eubank has received funding from the American Recovery and Reinvestment Act to develop computer models of infectious disease emergence and spread.

Dieter Soll is one of eight NIGMS grantees at Yale University receiving funding from the American Recovery and Reinvestment Act.

NIGMS grantee Stephen Eubank will use funds from the American Recovery and Reinvestment Act to extend our understanding of disease models and expand their use in policymaking. 

NIGMS grantee Emily Scott has received funding from the American Recovery and Reinvestment Act to further her lung cancer research at the University of Kansas. Watch a video of Scott discussing her research.

NIGMS grantee W. Allen Miller is among the researchers at Iowa State University receiving American Recovery and Reinvestment Act funding.

NIGMS grantee Donald Jarvis is among the scientists at the University of Wyoming receiving funding from the American Recovery and Reinvestment Act. 

NIGMS grantee Aleksandar Popadic is among the researchers at Wayne State University receiving American Recovery and Reinvestment Act funding. Popadic studies the molecular processes underlying variation in organ and tissue growth.

Funding from the American Recovery and Reinvestment Act supports summer research experiences at the University of Alabama at Birmingham.

NIGMS grantees Gayle Slaughter and Michael J. Friedlander were awarded American Recovery and Reinvestment Act funding to support training and recruitment of new students and faculty at Baylor College of Medicine. 

NIGMS grantees are among the researchers at Emory University receiving American Recovery and Reinvestment Act funding. 

The University of Texas at Brownsville and Texas Southmost College will receive $164,171 for the university’s MBRS RISE program. The funding is part of the American Recovery and Reinvestment Act.

Andy Catling, a pharmacology professor at the Louisiana State University Health Sciences Center in New Orleans, has received a $177,500 supplement to his NIGMS grant to support research cell receptor systems.

California State University, Bakersfield, has received a $78,775 grant to prepare students for a future in biomedical research through the university’s MARC program. The funding is part of the American Recovery and Reinvestment Act. 

NIGMS grantee Edward Seto is among the researchers at the H. Lee Moffitt Cancer Center & Research Institute receiving American Recovery and Reinvestment Act funds. 

NIGMS grantee Maria Almira Corriea is among the researchers at the University of California, San Francisco, receiving economic stimulus grants from NIH.